Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients

Leukemia and Lymphoma

Volumn 39, Issue 1-2, 2000, Pages 77-85

  Romaguera, J E ^a   Khouri, I F ^a   Kantarjian, H M ^a   Hagemeister, F B ^a   Rodriguez, M A ^a   McLaughlin, P ^a   Sarris, A H ^a   Younes, A ^a   Rodriguez, J ^a   Cabanillas, F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Elderly; Hyper CVAD therapy; Mantle cell lymphoma

Indexed keywords

ACICLOVIR; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; VINCRISTINE;

AGED; ALOPECIA; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DEATH; DIARRHEA; DOSE RESPONSE; DRUG MEGADOSE; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; MALE; MANTLE CELL LYMPHOMA; MINIMAL RESIDUAL DISEASE; MUCOSA INFLAMMATION; NAUSEA; NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RASH; STEM CELL TRANSPLANTATION; VOMITING;

EID: 0033838398     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009053541     Document Type: Article

References (16)

1. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data
2. Three histological variants of mantle cell lymphoma (MCL) exhibit striking heterogeneity in clinical behavior and biological features
3. Multicenter randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis
4. Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20 year period
5. Mantle cell lymphoma: A clinicopathologic study of 80 cases
6. Efficacy of four different regimens in 64 mantle cell lymphoma cases. Clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes
7. Patterns of survival in mantle cell lymphomas
8. Which treatment for mantle cell lymphoma patients in 1998?
9. A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including mucose-associated lymphoid tissue and monocytoid B cell categories): A Southwest Oncology Group study
10. Mantle cell lymphoma (MCL) has a poorer prognosis than follicular non-Hodgkin's lymphoma (FONHL); however, high dose therapy (HDC) and autologous stem cell transplantation (ASCT) may overcome treatment resistance in MCL
11. Mantle cell lymphoma (MCL): Hyper CVAD and High-dose Methotrexate/cytarabine followed by stem cell transplantation's an active regimen for aggressive mantle-cell lympoma
12. The Non-Hodgkin's Lymphoma classification project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
13. Use of avidin-biotin-peroxidase complex (ABC) and immunoperoxidase technique: Comparison between ABC and unlabeled antibosy (PAP) procedures
14. Non parametric estimation from incomplete observations
15. Mantle cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle center cell lymphomas: Results of a prospective comparative analysis of the German Low-grade Lymphoma Study Group
16. A multicenter, randomized phase II study of rituximab (chimeric anti-CD20 mAB) at two dosages in patients with relapsed or refractory intermediate or high grade NHL or in elderly patients in first-line therapy